The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Adams Thomas Phd since 2007.
The trader's CIK number is 1234366.
At the time of the last reporting, Adams Thomas Phd was the Chief Technology Off of Cardiff Oncology, Inc.. (stock ticker symbol CRDF).
Also see all insider trading activities at Cardiff Oncology, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | CRDF | 13,986 | $19,999 | 0 | $0 | 0 | $0 |
| 2018 | CRDF | 0 | $0 | 0 | $0 | 16,667 | $0 |
| 2017 | CRDF | 0 | $0 | 0 | $0 | 8,806 | $0 |
| 2013 | CRDF | 0 | $0 | 19,200 | $157,188 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | IRIS | 0 | $0 | 23,766 | $463,437 | 83,193 | $1,054,651 |
| 2011 | IRIS | 0 | $0 | 20,000 | $185,040 | 1,754 | $0 |
| 2007 | IRIS | 0 | $0 | 17,000 | $329,630 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | SGYP | 0 | $0 | 0 | $0 | 100,023 | $50,011 |
1. Cardiff Oncology, Inc. (CRDF)
2. Iris International Inc (IRIS)
3. Synergy Pharmaceuticals, Inc. (SGYP)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-05-14 | CRDF | Buy | 13,986 | 1.43 | 19,999 |
| 2018-01-02 | TROV | Option Ex | 16,667 | .00 | 0 |
| 2017-09-02 | TROV | Option Ex | 8,806 | .00 | 0 |
| 2013-08-30 | TROV | Sale | 15,000 | 8.06 | 120,900 |
| 2013-09-03 | TROV | Sale | 4,200 | 8.64 | 36,288 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-10-31 | IRIS | Sale | 23,766 | 19.50 | 463,437 |
| 2012-10-31 | IRIS | Option Ex | 82,023 | 12.86 | 1,054,651 |
| 2012-09-30 | IRIS | Option Ex | 293 | .00 | 0 |
| 2012-06-30 | IRIS | Option Ex | 292 | .00 | 0 |
| 2012-03-31 | IRIS | Option Ex | 292 | .00 | 0 |
| 2011-12-31 | IRIS | Option Ex | 293 | .00 | 0 |
| 2011-09-30 | IRIS | Option Ex | 292 | .00 | 0 |
| 2011-06-30 | IRIS | Option Ex | 293 | .00 | 0 |
| 2011-06-16 | IRIS | Sale | 20,000 | 9.25 | 185,040 |
| 2011-03-23 | IRIS | Option Ex | 1,169 | .00 | 0 |
| 2007-09-18 | IRIS | Sale | 17,000 | 19.39 | 329,630 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-07-03 | SGYP | Option Ex | 100,023 | .50 | 50,011 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Adams Thomas Phd (Chief Technology Off of Cardiff Oncology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.